Erkki Ruoslahti
Board Member
Lisata Therapeutics, Inc. (LSTA)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Erkki Ruoslahti
Erkki Ruoslahti is recorded as Board Member at Lisata Therapeutics, Inc. (LSTA). Lisata Therapeutics, Inc. reported in an 8-K filed September 15, 2022 that Erkki Ruoslahti was appointed Director, effective September 15, 2022.
“three former Cend directors, including Erkki Ruoslahti, M.D., Ph.D., Heidi Henson, and David Slack, MBA, were appointed as directors.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-01-01–present
-
2022-01-01–2023-07-11
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lisata Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- David J. Mazzo CEO, Board Member
- David J. Mazzo, Ph.D. CEO
- David Mazzo CEO, Board Member
- Gregory Brown Chairman
- Gregory Brown, M.D. Chairman
- Dr. Josh Lehrer COO
- Josh Lehrer COO
- Josh Lehrer, M.D., M.Phil., FACC COO
- Tariq Imam General Counsel
- James Nisco Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.